Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of CL-108 in Recreational Opioid Users
NCT02712554Phase 1Completed
- Sponsor
- Charleston Laboratories, Inc.
- Start
- Jun 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of hydrocodone + acetaminophen + promethazine in pain, nausea ((none)) and Vomiting (5 arms), sponsored by Charleston Laboratories, Inc. Primary endpoints: Maximum Effect of High Visual Analog Scale, Maximum Effect of Any Effects Visual Analog Scale and 1 more. Started Jun 2015; status: completed.
02
Drugs
hydrocodone + acetaminophen + promethazine
03
Conditions
painnausea ((none))Vomiting
Beyond the preview
Go deeper on NCT02712554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712554.